4.8 Article

Engineering of Amine Dehydrogenase for Asymmetric Reductive Amination of Ketone by Evolving Rhodococcus Phenylalanine Dehydrogenase

Journal

ACS CATALYSIS
Volume 5, Issue 2, Pages 1119-1122

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/cs501906r

Keywords

amine dehydrogenase; biocatalysis; biotransformation; chiral amine; directed evolution; reductive amination

Funding

  1. GlaxoSmithKline (GSK)
  2. Singapore Economic Development Board (EDB) [279-000-348-592]

Ask authors/readers for more resources

Triple mutant K66Q/S149G/N262C (TM_pheDH) of Rliodococcus phenylalanine dehydrogenase (pheDH) was engineered by directed evolution as the first enzyme for the highly enantioselective reductive amination of phenylacetone 1 and 4-phenyl-2-butanone 3, giving (R)-amphetamine 2 and (R)-1-methyl-3-phenylpropylamine 4 in >98% ee, respectively. The new amine dehydrogenase TM_pheDH with special substrate specificity is a valuable addition to the amine dehydrogenase family with very limited number, for asymmetric reductive amination of ketone, an important reaction in sustainable pharmaceutical manufacturing. Molecular docking provided insight into the role of key mutations of pheDH, being useful for engineering new amine dehydrogenases with higher activity and unique substrate scope.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available